Status:

RECRUITING

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

Lead Sponsor:

Genesis Athens Clinic

Collaborating Sponsors:

National and Kapodistrian University of Athens

Conditions:

Menopause, Premature

Menopause Related Conditions

Eligibility:

FEMALE

25-39 years

Phase:

PHASE2

PHASE3

Brief Summary

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve patients' hormonal profile in patients presenting with POI.

Detailed Description

This triple-blind Randomized Controlled Trial (RCT) aims to investigate the effectiveness of autologous PRP intra ovarian infusion on reactivating ovarian functionality and on promoting folliculogenes...

Eligibility Criteria

Inclusion

  • Age \< 40 years, presenting with amenorrhea or menstrual cycle irregularities for at least four months, and elevated FSH levels \>25 IU/L recorded on two occasions \>4 weeks apart
  • Normal Karyotype: 46, XX
  • Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.
  • Willing to comply with study requirements

Exclusion

  • Any pathological disorder related to reproductive system anatomy
  • AMH \> 8 pmol/L
  • Endometriosis
  • Adenomyosis
  • Fibroids and adhesions
  • Infections in reproductive system
  • Current or previous diagnosis of cancer in reproductive system
  • History of familiar cancer in reproductive system
  • Severe male factor infertility
  • Prior referral for PGT
  • Ovarian inaccessibility
  • Endocrinological disorders (Hypothalamus-Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)
  • BMI\>30 kg/m2 or BMI\<18.5 kg/m2
  • Systematic autoimmune disorders

Key Trial Info

Start Date :

July 30 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 30 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04031456

Start Date

July 30 2019

End Date

July 30 2026

Last Update

December 24 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Genesis AC

Athens, Greece, 15232